(1)
Zhang, Q. Pharmacoeconomic Evaluation of an Olanzapine-Containing Quadruple Antiemetic Regimen for the Prevention of CINV: An Efficacy-Cost Analysis. ESS 2026, 12, 98-103. https://doi.org/10.70267/lshe.20260112.